STILL DISEASE

Clinical trials for STILL DISEASE explained in plain language.

Never miss a new study

Get alerted when new STILL DISEASE trials appear

Sign up with your email to follow new studies for STILL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

New study tracks ILARIS use for rare inflammatory diseases

Disease control Not yet recruiting

This study will follow about 160 people with Familial Mediterranean Fever or Still's disease who have been taking ILARIS (canakinumab) for at least 6 months. Researchers want to see how well the drug controls the disease over time and what treatment patterns emerge. The goal is t…

Matched conditions: STILL DISEASE

Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated May 14, 2026 12:05 UTC

STILL DISEASE

Get alerted when new STILL DISEASE trials appear

New study tracks ILARIS use for rare inflammatory diseases